Trial intelligence / Profile preview

Dexamethasone for Dyspnea in Cancer Patients

NCT01670097Phase 2Completed

Sponsor
University of Texas MD Anderson Cancer Center
Start
Jan 2013
Primary completion
Aug 2020
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in Dyspnea comparing Dexamethasone with Placebo (2 arms). Primary endpoint: Dyspnea Numeric Rating Scale at Day 7. Started Jan 2013; status: completed.

02

Drugs

dexamethasone
03

Conditions

Dyspnea

Beyond the preview

Go deeper on NCT01670097.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01670097.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call